With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Treatment market in terms of revenue. Players, stakeholders, and other participants in the global Covid-19 Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026. The report offers an exhaustive geographical analysis of the global Covid-19 Treatment market, covering important regions, viz, North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
In the competitive analysis section of the report, leading as well as prominent players of the global Covid-19 Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Treatment market.
Respiratory support including oxygen therapy, high-flow nasal catheter oxygen therapy or non-invasive mechanical ventilation, invasive mechanical ventilation, extracorporeal membrane pneumonectomy (ECMO). Circulatory support refers to use vasoactive drug on the base of full fluid resuscitation and improved microcirculation. For else, antiviral medicine includs a-interferon, lopinavir/ritonavir, ribavirin, etc.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Covid-19 Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Respiratory Support
1.4.3 Circulatory Support.
1.4.4 Convalescent Plasma Therapy
1.4.5 Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin)
1.4.6 Antimicrobial Therapy
1.4.7 Renal Failure and Renal Replacement Therapy
1.4.8 Lung Replacement Therapy
1.4.9 Immunotherapy
1.4.10 Other therapeutic measures
1.5 Market by Application
1.5.1 Global Covid-19 Treatment Market Share by Application: 2020 VS 2026
1.5.2 Children
1.5.3 Adult
1.5.4 Special Groups
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Covid-19 Treatment Market Perspective (2015-2026)
2.2 Covid-19 Treatment Growth Trends by Regions
2.2.1 Covid-19 Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Covid-19 Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Covid-19 Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Covid-19 Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Covid-19 Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Treatment Players by Market Size
3.1.1 Global Top Covid-19 Treatment Players by Revenue (2015-2020)
3.1.2 Global Covid-19 Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Covid-19 Treatment Market Concentration Ratio
3.2.1 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Covid-19 Treatment Revenue in 2019
3.3 Covid-19 Treatment Key Players Head office and Area Served
3.4 Key Players Covid-19 Treatment Product Solution and Service
3.5 Date of Enter into Covid-19 Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Covid-19 Treatment Historic Market Size by Type (2015-2020)
4.2 Global Covid-19 Treatment Forecasted Market Size by Type (2021-2026)
5 Covid-19 Treatment Breakdown Data by Application (2015-2026)
5.1 Global Covid-19 Treatment Market Size by Application (2015-2020)
5.2 Global Covid-19 Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Covid-19 Treatment Market Size (2015-2020)
6.2 Covid-19 Treatment Key Players in North America (2019-2020)
6.3 North America Covid-19 Treatment Market Size by Type (2015-2020)
6.4 North America Covid-19 Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Covid-19 Treatment Market Size (2015-2020)
7.2 Covid-19 Treatment Key Players in Europe (2019-2020)
7.3 Europe Covid-19 Treatment Market Size by Type (2015-2020)
7.4 Europe Covid-19 Treatment Market Size by Application (2015-2020)
8 China
8.1 China Covid-19 Treatment Market Size (2015-2020)
8.2 Covid-19 Treatment Key Players in China (2019-2020)
8.3 China Covid-19 Treatment Market Size by Type (2015-2020)
8.4 China Covid-19 Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Covid-19 Treatment Market Size (2015-2020)
9.2 Covid-19 Treatment Key Players in Japan (2019-2020)
9.3 Japan Covid-19 Treatment Market Size by Type (2015-2020)
9.4 Japan Covid-19 Treatment Market Size by Application (2015-2020)
10 South Korea
10.1 South Korea Covid-19 Treatment Market Size (2015-2020)
10.2 Covid-19 Treatment Key Players in South Korea (2019-2020)
10.3 South Korea Covid-19 Treatment Market Size by Type (2015-2020)
10.4 South Korea Covid-19 Treatment Market Size by Application (2015-2020)
11 Middle East
11.1 Middle East Covid-19 Treatment Market Size (2015-2020)
11.2 Covid-19 Treatment Key Players in Middle East (2019-2020)
11.3 Middle East Covid-19 Treatment Market Size by Type (2015-2020)
11.4 Middle East Covid-19 Treatment Market Size by Application (2015-2020)
12 Southeast Asia
12.1 Southeast Asia Covid-19 Treatment Market Size (2015-2020)
12.2 Covid-19 Treatment Key Players in Southeast Asia (2019-2020)
12.3 Southeast Asia Covid-19 Treatment Market Size by Type (2015-2020)
12.4 Southeast Asia Covid-19 Treatment Market Size by Application (2015-2020)
13 Central & South America
13.1 Central & South America Covid-19 Treatment Market Size (2015-2020)
13.2 Covid-19 Treatment Key Players in Central & South America (2019-2020)
13.3 Central & South America Covid-19 Treatment Market Size by Type (2015-2020)
.4 Central & South America Covid-19 Treatment Market Size by Application (2015-2020)
14 Key Players Profiles
14.1 Applied DNA Sciences, Inc
14.1.1 Applied DNA Sciences, Inc Company Details
14.1.2 Applied DNA Sciences, Inc Business Overview and Its Total Revenue
14.1.3 Applied DNA Sciences, Inc Covid-19 Treatment Introduction
14.1.4 Applied DNA Sciences, Inc Revenue in Covid-19 Treatment Business (2015-2020))
14.1.5 Applied DNA Sciences, Inc Recent Development
14.2 Codagenix
14.2.1 Codagenix Company Details
14.2.2 Codagenix Business Overview and Its Total Revenue
14.2.3 Codagenix Covid-19 Treatment Introduction
14.2.4 Codagenix Revenue in Covid-19 Treatment Business (2015-2020)
14.2.5 Codagenix Recent Development
14.3 GeoVax Labs, Inc.
14.3.1 GeoVax Labs, Inc. Company Details
14.3.2 GeoVax Labs, Inc. Business Overview and Its Total Revenue
14.3.3 GeoVax Labs, Inc. Covid-19 Treatment Introduction
14.3.4 GeoVax Labs, Inc. Revenue in Covid-19 Treatment Business (2015-2020)
14.3.5 GeoVax Labs, Inc. Recent Development
14.4 Takis Biotech
14.4.1 Takis Biotech Company Details
14.4.2 Takis Biotech Business Overview and Its Total Revenue
14.4.3 Takis Biotech Covid-19 Treatment Introduction
14.4.4 Takis Biotech Revenue in Covid-19 Treatment Business (2015-2020)
14.4.5 Takis Biotech Recent Development
14.5 Evvivax
14.5.1 Evvivax Company Details
14.5.2 Evvivax Business Overview and Its Total Revenue
14.5.3 Evvivax Covid-19 Treatment Introduction
14.5.4 Evvivax Revenue in Covid-19 Treatment Business (2015-2020)
14.5.5 Evvivax Recent Development
14.6 Zydus Cadila
14.6.1 Zydus Cadila Company Details
14.6.2 Zydus Cadila Business Overview and Its Total Revenue
14.6.3 Zydus Cadila Covid-19 Treatment Introduction
14.6.4 Zydus Cadila Revenue in Covid-19 Treatment Business (2015-2020)
14.6.5 Zydus Cadila Recent Development
14.7 MIGAL Galilee Research Institute
14.7.1 MIGAL Galilee Research Institute Company Details
14.7.2 MIGAL Galilee Research Institute Business Overview and Its Total Revenue
14.7.3 MIGAL Galilee Research Institute Covid-19 Treatment Introduction
14.7.4 MIGAL Galilee Research Institute Revenue in Covid-19 Treatment Business (2015-2020)
14.7.5 MIGAL Galilee Research Institute Recent Development
14.8 Generex Biotechnology Corporation
14.8.1 Generex Biotechnology Corporation Company Details
14.8.2 Generex Biotechnology Corporation Business Overview and Its Total Revenue
14.8.3 Generex Biotechnology Corporation Covid-19 Treatment Introduction
14.8.4 Generex Biotechnology Corporation Revenue in Covid-19 Treatment Business (2015-2020)
14.8.5 Generex Biotechnology Corporation Recent Development
14.9 Moderna Therapeutics
14.9.1 Moderna Therapeutics Company Details
14.9.2 Moderna Therapeutics Business Overview and Its Total Revenue
14.9.3 Moderna Therapeutics Covid-19 Treatment Introduction
14.9.4 Moderna Therapeutics Revenue in Covid-19 Treatment Business (2015-2020)
14.9.5 Moderna Therapeutics Recent Development
14.10 Novavax
14.10.1 Novavax Company Details
14.10.2 Novavax Business Overview and Its Total Revenue
14.10.3 Novavax Covid-19 Treatment Introduction
14.10.4 Novavax Revenue in Covid-19 Treatment Business (2015-2020)
14.10.5 Novavax Recent Development
14.11 Bravovax
10.11.1 Bravovax Company Details
10.11.2 Bravovax Business Overview and Its Total Revenue
10.11.3 Bravovax Covid-19 Treatment Introduction
10.11.4 Bravovax Revenue in Covid-19 Treatment Business (2015-2020)
10.11.5 Bravovax Recent Development
14.12 Ascletis Pharma
10.12.1 Ascletis Pharma Company Details
10.12.2 Ascletis Pharma Business Overview and Its Total Revenue
10.12.3 Ascletis Pharma Covid-19 Treatment Introduction
10.12.4 Ascletis Pharma Revenue in Covid-19 Treatment Business (2015-2020)
10.12.5 Ascletis Pharma Recent Development
14.13 Janssen Pharmaceuticals
10.13.1 Janssen Pharmaceuticals Company Details
10.13.2 Janssen Pharmaceuticals Business Overview and Its Total Revenue
10.13.3 Janssen Pharmaceuticals Covid-19 Treatment Introduction
10.13.4 Janssen Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020)
10.13.5 Janssen Pharmaceuticals Recent Development
14.14 Altimmune
10.14.1 Altimmune Company Details
10.14.2 Altimmune Business Overview and Its Total Revenue
10.14.3 Altimmune Covid-19 Treatment Introduction
10.14.4 Altimmune Revenue in Covid-19 Treatment Business (2015-2020)
10.14.5 Altimmune Recent Development
14.15 Greffex Inc.
10.15.1 Greffex Inc. Company Details
10.15.2 Greffex Inc. Business Overview and Its Total Revenue
10.15.3 Greffex Inc. Covid-19 Treatment Introduction
10.15.4 Greffex Inc. Revenue in Covid-19 Treatment Business (2015-2020)
10.15.5 Greffex Inc. Recent Development
14.16 CanSino Biologics, Inc.
10.16.1 CanSino Biologics, Inc. Company Details
10.16.2 CanSino Biologics, Inc. Business Overview and Its Total Revenue
10.16.3 CanSino Biologics, Inc. Covid-19 Treatment Introduction
10.16.4 CanSino Biologics, Inc. Revenue in Covid-19 Treatment Business (2015-2020)
10.16.5 CanSino Biologics, Inc. Recent Development
14.17 ExpreS2ion Biotechnologies ApS
10.17.1 ExpreS2ion Biotechnologies ApS Company Details
10.17.2 ExpreS2ion Biotechnologies ApS Business Overview and Its Total Revenue
10.17.3 ExpreS2ion Biotechnologies ApS Covid-19 Treatment Introduction
10.17.4 ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Treatment Business (2015-2020)
10.17.5 ExpreS2ion Biotechnologies ApS Recent Development
14.18 Clover Biopharmaceuticals
10.18.1 Clover Biopharmaceuticals Company Details
10.18.2 Clover Biopharmaceuticals Business Overview and Its Total Revenue
10.18.3 Clover Biopharmaceuticals Covid-19 Treatment Introduction
10.18.4 Clover Biopharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020)
10.18.5 Clover Biopharmaceuticals Recent Development
14.19 Vaxil Bio Ltd.
10.19.1 Vaxil Bio Ltd. Company Details
10.19.2 Vaxil Bio Ltd. Business Overview and Its Total Revenue
10.19.3 Vaxil Bio Ltd. Covid-19 Treatment Introduction
10.19.4 Vaxil Bio Ltd. Revenue in Covid-19 Treatment Business (2015-2020)
10.19.5 Vaxil Bio Ltd. Recent Development
14.20 iBio Pharma Inc
10.20.1 iBio Pharma Inc Company Details
10.20.2 iBio Pharma Inc Business Overview and Its Total Revenue
10.20.3 iBio Pharma Inc Covid-19 Treatment Introduction
10.20.4 iBio Pharma Inc Revenue in Covid-19 Treatment Business (2015-2020)
10.20.5 iBio Pharma Inc Recent Development
14.21 Tonix Pharmaceuticals
10.21.1 Tonix Pharmaceuticals Company Details
10.21.2 Tonix Pharmaceuticals Business Overview and Its Total Revenue
10.21.3 Tonix Pharmaceuticals Covid-19 Treatment Introduction
10.21.4 Tonix Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020)
10.21.5 Tonix Pharmaceuticals Recent Development
14.22 Curevac
10.22.1 Curevac Company Details
10.22.2 Curevac Business Overview and Its Total Revenue
10.22.3 Curevac Covid-19 Treatment Introduction
10.22.4 Curevac Revenue in Covid-19 Treatment Business (2015-2020)
10.22.5 Curevac Recent Development
14.23 ImmunoPrecise
10.23.1 ImmunoPrecise Company Details
10.23.2 ImmunoPrecise Business Overview and Its Total Revenue
10.23.3 ImmunoPrecise Covid-19 Treatment Introduction
10.23.4 ImmunoPrecise Revenue in Covid-19 Treatment Business (2015-2020)
10.23.5 ImmunoPrecise Recent Development
15 Analyst's Viewpoints/Conclusions
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Disclaimer
16.3 Author Details
Table 1. Covid-19 Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Covid-19 Treatment Revenue
Table 3. Ranking of Global Top Covid-19 Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Respiratory Support
Table 6. Key Players of Circulatory Support.
Table 7. Key Players of Convalescent Plasma Therapy
Table 8. Key Players of Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin)
Table 9. Key Players of Antimicrobial Therapy
Table 10. Key Players of Renal Failure and Renal Replacement Therapy
Table 11. Key Players of Lung Replacement Therapy
Table 12. Key Players of Immunotherapy
Table 13. Key Players of Other therapeutic measures
Table 14. Global Covid-19 Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Covid-19 Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Covid-19 Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Covid-19 Treatment Market Share by Regions (2015-2020)
Table 18. Global Covid-19 Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Covid-19 Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Covid-19 Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Covid-19 Treatment Players
Table 25. Global Covid-19 Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Covid-19 Treatment Market Share by Players (2015-2020)
Table 27. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2019)
Table 28. Global Covid-19 Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Covid-19 Treatment Product Solution and Service
Table 31. Date of Enter into Covid-19 Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Covid-19 Treatment Market Size Share by Type (2015-2020)
Table 35. Global Covid-19 Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Covid-19 Treatment Market Size Share by Application (2015-2020)
Table 37. Global Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Covid-19 Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Covid-19 Treatment Market Share (2019-2020)
Table 41. North America Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Covid-19 Treatment Market Share by Type (2015-2020)
Table 43. North America Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Covid-19 Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Covid-19 Treatment Market Share (2019-2020)
Table 47. Europe Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Covid-19 Treatment Market Share by Type (2015-2020)
Table 49. Europe Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Covid-19 Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Covid-19 Treatment Market Share (2019-2020)
Table 53. China Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Covid-19 Treatment Market Share by Type (2015-2020)
Table 55. China Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Covid-19 Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Covid-19 Treatment Market Share (2019-2020)
Table 59. Japan Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Covid-19 Treatment Market Share by Type (2015-2020)
Table 61. Japan Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Covid-19 Treatment Market Share by Application (2015-2020)
Table 63. South Korea Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 64. South Korea Key Players Covid-19 Treatment Market Share (2019-2020)
Table 65. South Korea Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. South Korea Covid-19 Treatment Market Share by Type (2015-2020)
Table 67. South Korea Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. South Korea Covid-19 Treatment Market Share by Application (2015-2020)
Table 69. Middle East Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 70. Middle East Key Players Covid-19 Treatment Market Share (2019-2020)
Table 71. Middle East Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Middle East Covid-19 Treatment Market Share by Type (2015-2020)
Table 73. Middle East Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Middle East Covid-19 Treatment Market Share by Application (2015-2020)
Table 75. Southeast Asia Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 76. Southeast Asia Key Players Covid-19 Treatment Market Share (2019-2020)
Table 77. Southeast Asia Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Southeast Asia Covid-19 Treatment Market Share by Type (2015-2020)
Table 79. Southeast Asia Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Southeast Asia Covid-19 Treatment Market Share by Application (2015-2020)
Table 81. Central & South America Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$)
Table 82. Central & South America Key Players Covid-19 Treatment Market Share (2019-2020)
Table 83. Central & South America Covid-19 Treatment Market Size by Type (2015-2020) (Million US$)
Table 84. Central & South America Covid-19 Treatment Market Share by Type (2015-2020)
Table 85. Central & South America Covid-19 Treatment Market Size by Application (2015-2020) (Million US$)
Table 86. Central & South America Covid-19 Treatment Market Share by Application (2015-2020)
Table 87. Applied DNA Sciences, Inc Company Details
Table 88. Applied DNA Sciences, Inc Business Overview
Table 89. Applied DNA Sciences, Inc Product
Table 90. Applied DNA Sciences, Inc Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 91. Applied DNA Sciences, Inc Recent Development
Table 92. Codagenix Company Details
Table 93. Codagenix Business Overview
Table 94. Codagenix Product
Table 95. Codagenix Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 96. Codagenix Recent Development
Table 97. GeoVax Labs, Inc. Company Details
Table 98. GeoVax Labs, Inc. Business Overview
Table 99. GeoVax Labs, Inc. Product
Table 100. GeoVax Labs, Inc. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 101. GeoVax Labs, Inc. Recent Development
Table 102. Takis Biotech Company Details
Table 103. Takis Biotech Business Overview
Table 104. Takis Biotech Product
Table 105. Takis Biotech Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 106. Takis Biotech Recent Development
Table 107. Evvivax Company Details
Table 108. Evvivax Business Overview
Table 109. Evvivax Product
Table 110. Evvivax Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 111. Evvivax Recent Development
Table 112. Zydus Cadila Company Details
Table 113. Zydus Cadila Business Overview
Table 114. Zydus Cadila Product
Table 115. Zydus Cadila Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 116. Zydus Cadila Recent Development
Table 117. MIGAL Galilee Research Institute Company Details
Table 118. MIGAL Galilee Research Institute Business Overview
Table 119. MIGAL Galilee Research Institute Product
Table 120. MIGAL Galilee Research Institute Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 121. MIGAL Galilee Research Institute Recent Development
Table 122. Generex Biotechnology Corporation Business Overview
Table 123. Generex Biotechnology Corporation Product
Table 124. Generex Biotechnology Corporation Company Details
Table 125. Generex Biotechnology Corporation Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 126. Generex Biotechnology Corporation Recent Development
Table 127. Moderna Therapeutics Company Details
Table 128. Moderna Therapeutics Business Overview
Table 129. Moderna Therapeutics Product
Table 130. Moderna Therapeutics Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 131. Moderna Therapeutics Recent Development
Table 132. Novavax Company Details
Table 133. Novavax Business Overview
Table 134. Novavax Product
Table 135. Novavax Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 136. Novavax Recent Development
Table 137. Bravovax Company Details
Table 138. Bravovax Business Overview
Table 139. Bravovax Product
Table 140. Bravovax Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 141. Bravovax Recent Development
Table 142. Ascletis Pharma Company Details
Table 143. Ascletis Pharma Business Overview
Table 144. Ascletis Pharma Product
Table 145. Ascletis Pharma Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 146. Ascletis Pharma Recent Development
Table 147. Janssen Pharmaceuticals Company Details
Table 148. Janssen Pharmaceuticals Business Overview
Table 149. Janssen Pharmaceuticals Product
Table 150. Janssen Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 151. Janssen Pharmaceuticals Recent Development
Table 152. Altimmune Company Details
Table 153. Altimmune Business Overview
Table 154. Altimmune Product
Table 155. Altimmune Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 156. Altimmune Recent Development
Table 157. Greffex Inc. Company Details
Table 158. Greffex Inc. Business Overview
Table 159. Greffex Inc. Product
Table 160. Greffex Inc. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 161. Greffex Inc. Recent Development
Table 162. CanSino Biologics, Inc. Company Details
Table 163. CanSino Biologics, Inc. Business Overview
Table 164. CanSino Biologics, Inc. Product
Table 165. CanSino Biologics, Inc. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 166. CanSino Biologics, Inc. Recent Development
Table 167. ExpreS2ion Biotechnologies ApS Company Details
Table 168. ExpreS2ion Biotechnologies ApS Business Overview
Table 169. ExpreS2ion Biotechnologies ApS Product
Table 170. ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 171. ExpreS2ion Biotechnologies ApS Recent Development
Table 172. Clover Biopharmaceuticals Company Details
Table 173. Clover Biopharmaceuticals Business Overview
Table 174. Clover Biopharmaceuticals Product
Table 175. Clover Biopharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 176. Clover Biopharmaceuticals Recent Development
Table 177. Vaxil Bio Ltd. Company Details
Table 178. Vaxil Bio Ltd. Business Overview
Table 179. Vaxil Bio Ltd. Product
Table 180. Vaxil Bio Ltd. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 181. Vaxil Bio Ltd. Recent Development
Table 182. iBio Pharma Inc Company Details
Table 183. iBio Pharma Inc Business Overview
Table 184. iBio Pharma Inc Product
Table 185. iBio Pharma Inc Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 186. iBio Pharma Inc Recent Development
Table 187. Tonix Pharmaceuticals Company Details
Table 188. Tonix Pharmaceuticals Business Overview
Table 189. Tonix Pharmaceuticals Product
Table 190. Tonix Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 191. Tonix Pharmaceuticals Recent Development
Table 192. Curevac Company Details
Table 193. Curevac Business Overview
Table 194. Curevac Product
Table 195. Curevac Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 196. Curevac Recent Development
Table 197. ImmunoPrecise Company Details
Table 198. ImmunoPrecise Business Overview
Table 199. ImmunoPrecise Product
Table 200. ImmunoPrecise Revenue in Covid-19 Treatment Business (2015-2020) (Million US$)
Table 201. ImmunoPrecise Recent Development
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Treatment Market Share by Type: 2020 VS 2026
Figure 2. Respiratory Support Features
Figure 3. Circulatory Support. Features
Figure 4. Convalescent Plasma Therapy Features
Figure 5. Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin) Features
Figure 6. Antimicrobial Therapy Features
Figure 7. Renal Failure and Renal Replacement Therapy Features
Figure 8. Lung Replacement Therapy Features
Figure 9. Immunotherapy Features
Figure 10. Other therapeutic measures Features
Figure 11. Global Covid-19 Treatment Market Share by Application: 2020 VS 2026
Figure 12. Children Case Studies
Figure 13. Adult Case Studies
Figure 14. Special Groups Case Studies
Figure 15. Covid-19 Treatment Report Years Considered
Figure 16. Global Covid-19 Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Covid-19 Treatment Market Share by Regions: 2020 VS 2026
Figure 18. Global Covid-19 Treatment Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Covid-19 Treatment Market Share by Players in 2019
Figure 21. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Covid-19 Treatment Revenue in 2019
Figure 23. North America Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. South Korea Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Middle East Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Applied DNA Sciences, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Applied DNA Sciences, Inc Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 33. Codagenix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Codagenix Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 35. GeoVax Labs, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. GeoVax Labs, Inc. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 37. Takis Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Takis Biotech Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 39. Evvivax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Evvivax Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 41. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Zydus Cadila Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 43. MIGAL Galilee Research Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. MIGAL Galilee Research Institute Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 45. Generex Biotechnology Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Generex Biotechnology Corporation Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 47. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Moderna Therapeutics Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 49. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novavax Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 51. Bravovax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bravovax Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 53. Ascletis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ascletis Pharma Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 55. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Janssen Pharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 57. Altimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Altimmune Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 59. Greffex Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Greffex Inc. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 61. CanSino Biologics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. CanSino Biologics, Inc. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 63. ExpreS2ion Biotechnologies ApS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. ExpreS2ion Biotechnologies ApS Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 65. Clover Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Clover Biopharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 67. Vaxil Bio Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Vaxil Bio Ltd. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
Figure 69. iBio Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. iBio Pharma Inc Revenue Growth Rate in Covid-19 Treatment Business (2015-2020)
$3900
$7800
